The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Clinical Mass Spectrometry Market Research Report 2024

Global Clinical Mass Spectrometry Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1678637

No of Pages : 86

Ask Your Query

Synopsis

Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics. Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.

The global Clinical Mass Spectrometry market was valued at US$ 833.2 million in 2023 and is anticipated to reach US$ 1647.8 million by 2030, witnessing a CAGR of 10.1% during the forecast period 2024-2030.

Global clinical mass spectrometry key players include Danaher, Bruker, Thermo Fisher, Agilent, Waters, etc. Global top 5 manufacturers hold a share about 80%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 34%.In terms of product, LC-MS is the largest segment, with a share over 75%. And in terms of application, the largest application is clinical diagnostics, followed by clinical research.

This report aims to provide a comprehensive presentation of the global market for Clinical Mass Spectrometry, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Mass Spectrometry.

Report Scope

The Clinical Mass Spectrometry market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Mass Spectrometry market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Clinical Mass Spectrometry manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Danaher
  • Bruker
  • Agilent
  • Thermo Fisher
  • Waters
  • Shidmazu
  • Perkin Elmer

Segment by Type

  • LC-MS
  • MALDI-TOF MS
  • Other

Segment by Application

  • Clinical Diagnostics
  • Clinical Research

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Clinical Mass Spectrometry manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Clinical Mass Spectrometry in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Clinical Mass Spectrometry Market Overview
1.1 Product Overview and Scope of Clinical Mass Spectrometry
1.2 Clinical Mass Spectrometry Segment by Type
1.2.1 Global Clinical Mass Spectrometry Market Value Comparison by Type (2024-2030)
1.2.2 LC-MS
1.2.3 MALDI-TOF MS
1.2.4 Other
1.3 Clinical Mass Spectrometry Segment by Application
1.3.1 Global Clinical Mass Spectrometry Market Value by Application: (2024-2030)
1.3.2 Clinical Diagnostics
1.3.3 Clinical Research
1.4 Global Clinical Mass Spectrometry Market Size Estimates and Forecasts
1.4.1 Global Clinical Mass Spectrometry Revenue 2019-2030
1.4.2 Global Clinical Mass Spectrometry Sales 2019-2030
1.4.3 Global Clinical Mass Spectrometry Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Clinical Mass Spectrometry Market Competition by Manufacturers
2.1 Global Clinical Mass Spectrometry Sales Market Share by Manufacturers (2019-2024)
2.2 Global Clinical Mass Spectrometry Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Clinical Mass Spectrometry Average Price by Manufacturers (2019-2024)
2.4 Global Clinical Mass Spectrometry Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Clinical Mass Spectrometry, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Clinical Mass Spectrometry, Product Type & Application
2.7 Clinical Mass Spectrometry Market Competitive Situation and Trends
2.7.1 Clinical Mass Spectrometry Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Clinical Mass Spectrometry Players Market Share by Revenue
2.7.3 Global Clinical Mass Spectrometry Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Clinical Mass Spectrometry Retrospective Market Scenario by Region
3.1 Global Clinical Mass Spectrometry Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Clinical Mass Spectrometry Global Clinical Mass Spectrometry Sales by Region: 2019-2030
3.2.1 Global Clinical Mass Spectrometry Sales by Region: 2019-2024
3.2.2 Global Clinical Mass Spectrometry Sales by Region: 2025-2030
3.3 Global Clinical Mass Spectrometry Global Clinical Mass Spectrometry Revenue by Region: 2019-2030
3.3.1 Global Clinical Mass Spectrometry Revenue by Region: 2019-2024
3.3.2 Global Clinical Mass Spectrometry Revenue by Region: 2025-2030
3.4 North America Clinical Mass Spectrometry Market Facts & Figures by Country
3.4.1 North America Clinical Mass Spectrometry Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Clinical Mass Spectrometry Sales by Country (2019-2030)
3.4.3 North America Clinical Mass Spectrometry Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Clinical Mass Spectrometry Market Facts & Figures by Country
3.5.1 Europe Clinical Mass Spectrometry Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Clinical Mass Spectrometry Sales by Country (2019-2030)
3.5.3 Europe Clinical Mass Spectrometry Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Clinical Mass Spectrometry Market Facts & Figures by Country
3.6.1 Asia Pacific Clinical Mass Spectrometry Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Clinical Mass Spectrometry Sales by Country (2019-2030)
3.6.3 Asia Pacific Clinical Mass Spectrometry Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Clinical Mass Spectrometry Market Facts & Figures by Country
3.7.1 Latin America Clinical Mass Spectrometry Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Clinical Mass Spectrometry Sales by Country (2019-2030)
3.7.3 Latin America Clinical Mass Spectrometry Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Clinical Mass Spectrometry Market Facts & Figures by Country
3.8.1 Middle East and Africa Clinical Mass Spectrometry Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Clinical Mass Spectrometry Sales by Country (2019-2030)
3.8.3 Middle East and Africa Clinical Mass Spectrometry Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Clinical Mass Spectrometry Sales by Type (2019-2030)
4.1.1 Global Clinical Mass Spectrometry Sales by Type (2019-2024)
4.1.2 Global Clinical Mass Spectrometry Sales by Type (2025-2030)
4.1.3 Global Clinical Mass Spectrometry Sales Market Share by Type (2019-2030)
4.2 Global Clinical Mass Spectrometry Revenue by Type (2019-2030)
4.2.1 Global Clinical Mass Spectrometry Revenue by Type (2019-2024)
4.2.2 Global Clinical Mass Spectrometry Revenue by Type (2025-2030)
4.2.3 Global Clinical Mass Spectrometry Revenue Market Share by Type (2019-2030)
4.3 Global Clinical Mass Spectrometry Price by Type (2019-2030)
5 Segment by Application
5.1 Global Clinical Mass Spectrometry Sales by Application (2019-2030)
5.1.1 Global Clinical Mass Spectrometry Sales by Application (2019-2024)
5.1.2 Global Clinical Mass Spectrometry Sales by Application (2025-2030)
5.1.3 Global Clinical Mass Spectrometry Sales Market Share by Application (2019-2030)
5.2 Global Clinical Mass Spectrometry Revenue by Application (2019-2030)
5.2.1 Global Clinical Mass Spectrometry Revenue by Application (2019-2024)
5.2.2 Global Clinical Mass Spectrometry Revenue by Application (2025-2030)
5.2.3 Global Clinical Mass Spectrometry Revenue Market Share by Application (2019-2030)
5.3 Global Clinical Mass Spectrometry Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Danaher
6.1.1 Danaher Corporation Information
6.1.2 Danaher Description and Business Overview
6.1.3 Danaher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Danaher Clinical Mass Spectrometry Product Portfolio
6.1.5 Danaher Recent Developments/Updates
6.2 Bruker
6.2.1 Bruker Corporation Information
6.2.2 Bruker Description and Business Overview
6.2.3 Bruker Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bruker Clinical Mass Spectrometry Product Portfolio
6.2.5 Bruker Recent Developments/Updates
6.3 Agilent
6.3.1 Agilent Corporation Information
6.3.2 Agilent Description and Business Overview
6.3.3 Agilent Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Agilent Clinical Mass Spectrometry Product Portfolio
6.3.5 Agilent Recent Developments/Updates
6.4 Thermo Fisher
6.4.1 Thermo Fisher Corporation Information
6.4.2 Thermo Fisher Description and Business Overview
6.4.3 Thermo Fisher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Thermo Fisher Clinical Mass Spectrometry Product Portfolio
6.4.5 Thermo Fisher Recent Developments/Updates
6.5 Waters
6.5.1 Waters Corporation Information
6.5.2 Waters Description and Business Overview
6.5.3 Waters Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Waters Clinical Mass Spectrometry Product Portfolio
6.5.5 Waters Recent Developments/Updates
6.6 Shidmazu
6.6.1 Shidmazu Corporation Information
6.6.2 Shidmazu Description and Business Overview
6.6.3 Shidmazu Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shidmazu Clinical Mass Spectrometry Product Portfolio
6.6.5 Shidmazu Recent Developments/Updates
6.7 Perkin Elmer
6.6.1 Perkin Elmer Corporation Information
6.6.2 Perkin Elmer Description and Business Overview
6.6.3 Perkin Elmer Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Perkin Elmer Clinical Mass Spectrometry Product Portfolio
6.7.5 Perkin Elmer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Clinical Mass Spectrometry Industry Chain Analysis
7.2 Clinical Mass Spectrometry Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Clinical Mass Spectrometry Production Mode & Process
7.4 Clinical Mass Spectrometry Sales and Marketing
7.4.1 Clinical Mass Spectrometry Sales Channels
7.4.2 Clinical Mass Spectrometry Distributors
7.5 Clinical Mass Spectrometry Customers
8 Clinical Mass Spectrometry Market Dynamics
8.1 Clinical Mass Spectrometry Industry Trends
8.2 Clinical Mass Spectrometry Market Drivers
8.3 Clinical Mass Spectrometry Market Challenges
8.4 Clinical Mass Spectrometry Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock